136 related articles for article (PubMed ID: 10781804)
1. Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells.
Skerjanc IS; Wilton S
FEBS Lett; 2000 Apr; 472(1):53-6. PubMed ID: 10781804
[TBL] [Abstract][Full Text] [Related]
2. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
Ridgeway AG; Wilton S; Skerjanc IS
J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
[TBL] [Abstract][Full Text] [Related]
3. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
4. The C-terminus of myogenin, but not MyoD, targets upregulation of MEF2C expression.
Rogerson PJ; Jamali M; Skerjanc IS
FEBS Lett; 2002 Jul; 524(1-3):134-8. PubMed ID: 12135755
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
6. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family.
Black BL; Ligon KL; Zhang Y; Olson EN
J Biol Chem; 1996 Oct; 271(43):26659-63. PubMed ID: 8900141
[TBL] [Abstract][Full Text] [Related]
7. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development.
Wang DZ; Valdez MR; McAnally J; Richardson J; Olson EN
Development; 2001 Nov; 128(22):4623-33. PubMed ID: 11714687
[TBL] [Abstract][Full Text] [Related]
8. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
Zang MX; Li Y; Xue LX; Jia HT; Jing H
J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
[TBL] [Abstract][Full Text] [Related]
9. Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2C regulates myocardial gene expression.
Zang MX; Li Y; Wang H; Wang JB; Jia HT
J Biol Chem; 2004 Dec; 279(52):54258-63. PubMed ID: 15485823
[TBL] [Abstract][Full Text] [Related]
10. Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro.
Voronova A; Al Madhoun A; Fischer A; Shelton M; Karamboulas C; Skerjanc IS
Nucleic Acids Res; 2012 Apr; 40(8):3329-47. PubMed ID: 22199256
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors.
Molkentin JD; Olson EN
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9366-73. PubMed ID: 8790335
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1.
Krainc D; Bai G; Okamoto S; Carles M; Kusiak JW; Brent RN; Lipton SA
J Biol Chem; 1998 Oct; 273(40):26218-24. PubMed ID: 9748305
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells.
Skerjanc IS; Petropoulos H; Ridgeway AG; Wilton S
J Biol Chem; 1998 Dec; 273(52):34904-10. PubMed ID: 9857019
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation.
Okamoto S; Krainc D; Sherman K; Lipton SA
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7561-6. PubMed ID: 10852968
[TBL] [Abstract][Full Text] [Related]
15. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
16. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.
Swanson BJ; Jäck HM; Lyons GE
Mol Immunol; 1998 Jun; 35(8):445-58. PubMed ID: 9798649
[TBL] [Abstract][Full Text] [Related]
17. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor MEF2C is required for craniofacial development.
Verzi MP; Agarwal P; Brown C; McCulley DJ; Schwarz JJ; Black BL
Dev Cell; 2007 Apr; 12(4):645-52. PubMed ID: 17420000
[TBL] [Abstract][Full Text] [Related]
19. Myocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in Drosophila.
Tanaka KK; Bryantsev AL; Cripps RM
Mol Cell Biol; 2008 Mar; 28(5):1616-29. PubMed ID: 18160709
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.
Lazaro JB; Bailey PJ; Lassar AB
Genes Dev; 2002 Jul; 16(14):1792-805. PubMed ID: 12130539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
